Although several biomarkers have been utilized to help in HF diagnosis (e.g. B-type Natriuretic Peptide (BNP) and N-terminal pro-BNP (NT-proBNP)), most of these biomarkers do not provide enough utility to distinguish between HFrEF and HFpEF in clinical practice [15]. This evidence concerns the gene NPPB and hydrops fetalis.